HKSH Cancer Centre Demonstrates Full Strength in Cancer Diagnosis and Treatment at World Cancer Congress 2026
The HKSH Cancer Centre showcased its clinical research and precision medicine technology at the World Cancer Congress 2026 in Hong Kong. The center is also preparing to co-host the 6th China Particle Radiotherapy Conference to further international collaboration.
Why it matters
Advancements in cancer treatment and international medical cooperation are critical for global health outcomes and the development of precision oncology.
HONG KONG SAR – Media OutReach Newswire – 16 October 2026 – HKSH Cancer Centre, a member of HKSH Medical Group (HKSH), was invited to take part in the World Cancer Congress 2026 held from 24 to 26 September, one of the world's most influential conferences on cancer control. The Union for International Cancer Control (UICC) and the Hong Kong Anti-Cancer Society (HKACS) co-hosted the Congress, which was held for the first time in Hong Kong, bringing together delegates from over 120 regions and countries for global exchange. HKSH took part under the theme "Beat Cancer, Fight Smarter" and presented its clinical experience, research, and technology innovations in the fight against cancer. Building on this momentum, and in support of the national Healthy China strategy, HKSH will co-host the 6th China Particle Radiotherapy Conference with the Shanghai Proton and Heavy Ion Center from 16 to 18 October 2026.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in